Advanced Search


Study ID Status Title Patient Level Data
201167 Completed A Phase I, open label, parallel group, three period, fixed sequence crossover study to evaluate the effect of dolutegravir on metformin pharmacokinetics in healthy adult subjects
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201186 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2011-2012
201188 Completed PGx7529: Exploratory Pharmacogenetic evaluation of Potential Modifiers of Duchenne Muscular Dystrophy patient response to Drisapersen
201198 Active, not recruiting Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults ≥ 65 years of age with and without Zostavax® vaccination at least 5 years earlier
201211 Completed A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD Study Listed on
201216 Active, Not Recruiting PGx7521: Evaluation of validated HLA markers with DILI in lapatinib clinical trial EGF106903
201223 Active, Not Recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201224 Completed Meta-Analysis Plan for GSK1550188, 201224, Concomitant Medications Analysis
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201234 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) compared to Fluzone® Quadrivalent in children 6 to 35 months of age Study Listed on
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201240 Completed Waterpipe use in the Middle East and North Africa: analysis of the BREATHE study
201243 Completed Distribution of body mass index among subjects with chronic obstructive pulmonary disease in the Middle East and North Africa: data from the BREATHE study
201244 Completed A randomized, double-blinded study to evaluate the ability of an acne treatment product to produce visible improvements in acne lesions over a 5 day period of once-daily use
201246 Completed A Phase I, Randomised, Double-blind (sponsor open), Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330811 in Healthy Subjects
201248 Completed An enabling study to compare the Inhalation Profiles of women in the third stage of labour to those of non-pregnant female volunteers and to explore whether there are any differences which could impact the delivery of an Inhaled medicinal product
201251 Completed Safety and immunogenicity study of GSK Biologicals’ Quadrivalent Influenza Candidate Vaccine (GSK23211381A) manufactured with a new process in adults and children
201275 Recruiting ALDREB Drug Use Investigation
201280 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC versus other treatments for COPD adult patients
201287 Completed A Randomized, Double-blind, Single-dose, Crossover Study to Compare Two Albiglutide Drug Products for Bioequivalence in Healthy Adult Subjects
201295 Active, Not Recruiting Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of COMPARZ Data
201302 Terminated A Phase 1 double-blind, randomised, placebo-controlled, dose escalating study to assess the safety and tolerability of single and multiple oral doses of CHR-5154 and the effect of the fasted and fed state on pharmacokinetics of CHR-5154 and CHR-5426 in healthy male volunteers
201304 Not yet recruiting DUAC Drug Use Investigation



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.